Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states

• Main Authors: Xinyao Qu (Author), Qiaohuan Deng (Author), Ying Li (Author), Peng Li (Author), Guangwen Liu (Author), Yanli Wang (Author), Zhengzhi Liu (Author), Shuang Yu (Author), Yang Cheng (Author), Yannan Zhou (Author), Jiahui Chen (Author), Qing Ren (Author), Zishu Yu (Author), Zhengjie Su (Author), Yicheng Zhao (Author), Haimiao Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We conducted a phase I bioequivalence trial in healthy Chinese subjects in the fasting and postprandial states. The goal of this trial was to compare the pharmacokinetics and safety of the test preparation Cefaclor granule (Disha Pharmaceutical Group Co., Ltd.) and the reference preparation Cefaclor...